Skip to main content
Log in

Familial Mediterranean Fever and Seronegative Arthritis

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Familial Mediterranean fever (FMF) is characterized by recurrent, self-limited episodes of polyserositis, with articular involvement also being a common manifestation. The pattern and joint predilection of arthritis show many similarities to those of spondyloarthritis. Moreover, case series suggest an increased prevalence of ankylosing spondylitis or spondyloarthritis among FMF patients. FMF is caused by mutations in the MEFV gene encoding pyrin, which is believed to be involved in regulation of interelukin-1β activation. Recent studies conducted in populations with a high background carrier rate of MEFV variants have reported an increased frequency of M694V among AS patients with no personal or family history of FMF. These findings are of interest, as both candidate gene and genome-wide association studies suggest that the interleukin-1 cytokine pathway may be implicated in the pathogenesis of ankylosing spondylitis. Therefore, association of M694V with ankylosing spondylitis can be recognized as a geographic region–specific risk factor affecting a common inflammatory pathway in the disease pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Onen F. Familial Mediterranean fever. Rheumatol Int. 2006;26:489–96.

    Article  PubMed  Google Scholar 

  2. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25–31.

    Article  Google Scholar 

  3. International FMF. Consortium: Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell. 1997;90:797–807.

    Article  Google Scholar 

  4. •• Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol. 2009, 27:621–668. The authors in this review proposed an updated classification for hereditary and acquired forms of autoinflammatory disorders based on molecular pathophysiology. FMF and AS are both included but in different categories.

    Article  PubMed  CAS  Google Scholar 

  5. Infevers: an online database for autoinflammatory mutations. Available at http://fmf.igh.cnrs.fr/ISSAID/infevers. Accessed March 2, 2011.

  6. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473–83.

    Article  PubMed  CAS  Google Scholar 

  7. • Marek-Yagel D, Bar-Joseph I, Pras E, Berkun Y. Is E148Q a benign polymorphism or a disease-causing mutation? The Journal of Rheumatology 2009, 36:2372. The authors extracted the data on E148Q from four published studies and found no difference between the Israeli controls and FMF patients.

    Article  PubMed  Google Scholar 

  8. Heller H, Gafni J, Michaeli D, et al. The arthritis of familial Mediterranean fever (FMF). Arthritis Rheum. 1966;9:1–17.

    Article  PubMed  CAS  Google Scholar 

  9. Garcia-Gonzalez A, Weisman MH. The arthritis of familial Mediterranean fever. Semin Arthritis Rheum. 1992;22:139–50.

    Article  PubMed  CAS  Google Scholar 

  10. Majeed HA, Rawashdeh M. The clinical patterns of arthritis in children with familial Mediterranean fever. QJM. 1997;90:37–43.

    PubMed  CAS  Google Scholar 

  11. Brik R, Shinawi M, Kasinetz L, Gershoni-Baruch R. The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease. Arthritis Rheum. 2001;44:1416–9.

    Article  PubMed  CAS  Google Scholar 

  12. Sneh E, Pras M, Michaeli D, et al. Protracted arthritis in familial Mediterranean fever. Rheumatol Rehabil. 1977;16:102–6.

    Article  PubMed  CAS  Google Scholar 

  13. Kaushansky K, Finerman GA, Schwabe AD. Chronic destructive arthritis in familial Mediterranean fever: the predominance of hip involvement and its management. Clin Orthop Relat Res. 1981:156–161.

  14. Salai M, Langevitz P, Blankstein A, et al. Total hip replacement in familial Mediterranean fever. Bull Hosp Jt Dis. 1993;53:25–8.

    PubMed  CAS  Google Scholar 

  15. Brik R, Shinawi M, Kepten I, et al. Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics. 1999;103:e70.

    Article  PubMed  CAS  Google Scholar 

  16. Tunca M, Akar S, Onen F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005;84:1–11.

    Article  Google Scholar 

  17. Cefle A, Kamali S, Sayarlioglu M, et al. A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis. Rheumatol Int. 2005;25:442–6.

    Article  PubMed  Google Scholar 

  18. Dilsen N. [Familial Mediterranean fever (periodic disease) associated with ankylopoietic spondylitis. (Apropos of a case)]. Turk Tip Cemiy Mecm. 1963;29:160–7.

    PubMed  CAS  Google Scholar 

  19. Dilsen NA. Ankylosing spondylitis in familial Mediterranean fever (periodic disease). Excerpta Medica Intern Congr ser. 1973;299:107.

    Google Scholar 

  20. Yazici H, Turunc M, Ozdogan H, et al. Observer variation in grading sacroiliac radiographs might be a cause of ‘sacroiliitis’ reported in certain disease states. Ann Rheum Dis. 1987;46:139–45.

    Article  PubMed  CAS  Google Scholar 

  21. Brodey PA, Wolff SM. Radiographic changes in the sacroiliac joints in familial Mediterranean fever. Radiology. 1975;114:331–3.

    PubMed  CAS  Google Scholar 

  22. Langevitz P, Livneh A, Zemer D, et al. Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum. 1997;27:67–72.

    Article  PubMed  CAS  Google Scholar 

  23. Baraliakos X, Listing J, von der Recke A, Braun J. The natural course of radiographic progression in ankylosing spondylitis—evidence for major individual variations in a large proportion of patients. Rheumatol. 2009, 36:997–1002. This study indicates that radiographic progression in AS is rather variable, and the authors propose to differentiate patients as fast, moderate, and slow radiographic progressors based on development of new syndesmophytes over time.

    Article  PubMed  Google Scholar 

  24. Boonen A, vander Cruyssen B, de Vlam K, et al. Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome. J Rheumatol. 2009;36:1249–55.

    Article  PubMed  Google Scholar 

  25. Nash P, Mease PJ, Braun J, van der Heijde D. Seronegative spondyloarthropathies: to lump or split? Ann Rheum Dis. 2005;64 Suppl 2:ii9–13.

    Article  PubMed  Google Scholar 

  26. Younes M, Kahn MF, Meyer O. Hip involvement in patients with familial Mediterranean fever. A review of ten cases. Joint Bone Spine. 2002;69:560–5.

    Article  PubMed  Google Scholar 

  27. •• Kasifoglu T, Calisir C, Cansu DU, Korkmaz C. The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol. 2009, 28:41–46. This study investigated the presence of sacroiliitis among FMF patients using MRI of the sacroiliac joints in addition to conventional radiography, and found a higher-than-expected prevalence of sacroiliitis. Almost all patients with FMF and sacroiliitis carried at least one allele of the M694V variant.

    Article  PubMed  Google Scholar 

  28. Akar S, Soysal O, Yuksel F, et al. High prevalence of axial spondyloarthritis in patients with familial Mediteranean fever, and a greater allelic frequency of M694V in familial Mediteranean fever patients with radiograpic sacroiliitis. Arthritis Rheum. 2010;62:S278.

    Google Scholar 

  29. Knockaert DC, Malysse IG, Peetermans WE. Ankylosing spondylitis. An unusual manifestation of familial Mediterranean fever. Report of a case complicated by amyloidosis and polyneuropathy. Clin Rheumatol. 1989;8:408–12.

    Article  PubMed  CAS  Google Scholar 

  30. Sari I, Simsek I, Guvenc I, et al. Osteopoikilosis coexistent with ankylosing spondylitis and familial Mediterranean fever. Rheumatol Int. 2009;29:321–3.

    Article  PubMed  Google Scholar 

  31. Duman I, Balaban B, Tugcu I, Dincer K. Familial mediterranean fever unusually coexisted in an ankylosing spondylitis patient. MEFV mutation has any role? Rheumatol Int. 2007;27:689–90.

    Article  PubMed  Google Scholar 

  32. Kaushik P, el-Sobkie NI, Shehab D, Malaviya AN. Familial Mediterranean fever with HLA B-27 positive ankylosing spondylitis in a young Armenian man. Clin Exp Rheumatol. 1999;17:387–8.

    PubMed  CAS  Google Scholar 

  33. Keles I, Aydin G, Tosun A, et al. Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: a case report and review of the literature. Rheumatol Int. 2006;26:846–51.

    Article  PubMed  Google Scholar 

  34. Akar S, Birlik M, Sari I, et al. M694V mutation may have a role in susceptibility to ankylosing spondylitis. Rheumatol Int. 2009;29:1259–60.

    Article  PubMed  Google Scholar 

  35. •• Cosan F, Ustek D, Oku B, et al. Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis. Arthritis Rheum. 2010, 62:3232–3236. This study reported a significantly higher frequency of M694V among AS patients with no personal or family history of FMF as compared with healthy controls.

    Article  PubMed  Google Scholar 

  36. •• Akkoc N, Sari I, Akar S, et al. Increased prevalence of M694V in patients with ankylosing spondylitis: additional evidence for a link with familial Mediterranean fever. Arthritis Rheum. 2010, 62:3059–3063. This study reported a significantly higher frequency of M694V among AS patients than in healthy controls and patients with rheumatoid arthritis.

    Article  PubMed  CAS  Google Scholar 

  37. Durmus D, Alayli G, Cengiz K, et al. Clinical significance of MEFV mutations in ankylosing spondylitis. Joint Bone Spine. 2009;76:260–4.

    Article  PubMed  CAS  Google Scholar 

  38. Akkoc N, Gul A. Comment on the article by Durmus et al. “Clinical significance of MEFV mutations in ankylosing spondylitis”. Joint Bone Spine. 2010;77:281.

    Article  PubMed  Google Scholar 

  39. Cinar M, Dinc A, Simsek I, et al. The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study. Rheumatol Int. 2008;29:37–42.

    Article  PubMed  Google Scholar 

  40. Maras Y, Calguneri M, Akdogan A, et al. MEFV mutations frequency and effect on disease severity in ankyloing spondylitis EULAR Meeting Abstracts. 2007, 66:400.

  41. •• Reveille JD. The genetic basis of spondyloarthritis. Ann Rheum Dis. 2011, 70 Suppl 1:i44-50. This is a very comprehensive review on the genetics of AS.

    Article  PubMed  Google Scholar 

  42. Burton PR, Clayton DG, Cardon LR, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39:1329–37.

    Article  PubMed  CAS  Google Scholar 

  43. •• Reveille JD, Sims AM, Danoy P, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet. 2010, 42:123–127. This recent genome-wide association study confirmed the strong association of the HLA-B region and also revealed several non-HLA susceptibility genes for AS.

    Article  PubMed  CAS  Google Scholar 

  44. Sims AM, Timms AE, Bruges-Armas J, et al. Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis. 2008;67:1305–9.

    Article  PubMed  Google Scholar 

  45. Carter KW, Pluzhnikov A, Timms AE, et al. Combined analysis of three whole genome linkage scans for ankylosing spondylitis. Rheumatology (Oxford). 2007;46:763–71.

    Article  CAS  Google Scholar 

  46. •• Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol. 2010, 10:89–102. This paper provided a very comprehensive review of the IL-1 family in health and disease.

    Article  PubMed  CAS  Google Scholar 

  47. Chae JJ, Wood G, Richard K, et al. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood. 2008;112:1794–803.

    Article  PubMed  CAS  Google Scholar 

  48. Yu JW, Wu J, Zhang Z, et al. Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ. 2006;13:236–49.

    Article  PubMed  CAS  Google Scholar 

  49. Papin S, Cuenin S, Agostini L, et al. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ. 2007;14:1457–66.

    Article  PubMed  CAS  Google Scholar 

  50. Waite AL, Schaner P, Hu C, et al. Pyrin and ASC co-localize to cellular sites that are rich in polymerizing actin. Exp Biol Med (Maywood). 2009;234:40–52.

    Article  CAS  Google Scholar 

  51. Shiohara M, Taniguchi S, Masumoto J, et al. ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochem Biophys Res Commun. 2002;293:1314–8.

    Article  PubMed  CAS  Google Scholar 

  52. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10:417–26.

    Article  PubMed  CAS  Google Scholar 

  53. Dowds TA, Masumoto J, Chen FF, et al. Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem Biophys Res Commun. 2003;302:575–80.

    Article  PubMed  CAS  Google Scholar 

  54. Stehlik C, Lee SH, Dorfleutner A, et al. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J Immunol. 2003;171:6154–63.

    PubMed  CAS  Google Scholar 

  55. Lachmann HJ, Sengul B, Yavuzsen TU, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45:746–50.

    Article  CAS  Google Scholar 

  56. Booty MG, Chae JJ, Masters SL, et al. Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum. 2009, 60:1851–1861. This study described patients with classical features of FMF despite a single MEFV mutation.

    Article  PubMed  CAS  Google Scholar 

  57. Ustek D, Ekmekci C, Oku B, et al. MEFV gene 3′-UTR Alu repeat polymorphisms in patients with familial Mediterranean fever. Clin Exp Rheumatol. 2008;26:S72–6.

    PubMed  CAS  Google Scholar 

  58. Ben-Chetrit E, Peleg H, Aamar S, Heyman SN. The spectrum of MEFV clinical presentations—is it familial Mediterranean fever only? Rheumatology (Oxford). 2009, 48:1455–1459. This study discusses the atypical autoinflammatory clinical features in patients carrying MEFV variations.

    Article  Google Scholar 

  59. Kone-Paut I, Hentgen V, Guillaume-Czitrom S, et al. The clinical spectrum of 94 patients carrying a single mutated MEFV allele. Rheumatology (Oxford). 2009;48:840–2.

    Article  CAS  Google Scholar 

  60. Touitou I, Magne X, Molinari N, et al. MEFV mutations in Behcet’s disease. Hum Mutat. 2000;16:271–2.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nurullah Akkoc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akkoc, N., Gul, A. Familial Mediterranean Fever and Seronegative Arthritis. Curr Rheumatol Rep 13, 388–394 (2011). https://doi.org/10.1007/s11926-011-0191-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-011-0191-9

Keywords

Navigation